Subscribe now

The story broke on Friday that Quebec’s financial regulator, the AMF, alleges that executive chairman Charles Pellerin shared privileged information with nine family members and acquaintances ahead of TerraVest’s announcement of the EnTrans acquisition in March 2025. EnTrans was TerraVest’s largest ever deal by a considerable margin, a US$546 million acquisition of a premier North American tank trailer manufacturer that sent the stock from around C$109 to a peak of C$150 in the week following the announcement, reflecting how positively the market received the transaction at the time. The AMF estimates that the theoretical profits made by those individuals amounted to close to C$6.8 million. No charges have been filed. The board, excluding Pellerin, has commenced a formal review and stated it will cooperate fully with regulators. Based on that statement, this appears to be the actions of Mr. Pellerin alone rather than any wider failing within the company.

Before going further, just a note on the direction of the alleged trading. This is alleged inside buying ahead of positive news, not selling ahead of bad news. If the AMF’s account is correct, the implication is that Charles himself thought the EnTrans deal was a steal and acted accordingly, which is a different type of insider trade than say, an insider selling shares ahead of a profit warning, although it is not any less wrong, if true.

Losing Pellerin would be a very significant blow to TerraVest, and I think that needs to be said plainly. He is not a passive chairman in any sense of the word. Guy Gottfried of Rational Investment Group, who has followed TerraVest more closely than almost anyone outside the company, has described Charles as “a force of nature” and the architect of TerraVest’s M&A strategy, and from everything I have read and heard about how the company operates, that description rings true. When the Jerico business that Charles had built combined with TerraVest in 2014, he chose to take his entire consideration in TerraVest stock rather than cash, a decision that tells you a great deal about his conviction and his alignment. He has been hands-on ever since, instrumental in shaping the deal culture, the acquisition pipeline, and the strategic direction of the business. The investment case is certainly somewhat diminished by his potential departure even if everything else remains intact. These developments have been frustrating and costly for shareholders, and I am sure TVK insiders feel the same way.

The likely paths from here are reasonably clear.

• (a) No wrongdoing is found and no charges are brought, in which case a decision still needs to be made about whether Pellerin remains as chairman. Given the nature of the allegations, I view this as the less likely outcome.

• (b) The regulators find wrongdoing, in which case TerraVest will either decide or be compelled to remove Pellerin from the board, which I view as the more probable resolution.

There is also the separate question of Pellerin’s 15.7% stake. Should he exit the board he may choose to sell some or all of that position, creating meaningful overhang, or he may hold if he retains confidence in TerraVest’s long-term compounding ability.

There are further near-term risks worth naming. Law firms have already announced investigations into potential investor class actions, creating additional legal cost overhang and management distraction. The historical pattern with insider trading allegations at fundamentally sound businesses tends to involve six to twelve months of stock weakness and a governance discount that can persist for one to three years. That is the realistic timeframe to work with.

What gives me confidence is the quality of the team that remains. Dustin Haw became CEO of TerraVest in 2017, when he was in his early thirties. Dustin has compounded EBITDA per share at TVK at a rate of c.35% annually for eight years. He is analytical, disciplined in capital allocation, and has meaningful personal skin in the game. Mitch Gilbert, the CIO, spent fourteen years in M&A at a major Canadian bank before joining TerraVest in 2013 and has been central to the deal sourcing and execution that has driven value creation. Both have a long runway ahead and both appear untouched by the allegations. At the subsidiary level, John Jacob at Highland Tank and Ken Wagner and his team at Green Energy Services are entrepreneurs executing their own bolt-on strategies within the platform. The continued presence of these people should mean the compounding engine remains largely intact.

The table below captures just how exceptional the track record has been at TerraVest over the last eight years since Dustin became CEO, with shareholder returns to today’s C$108 stock price, not including dividends, which have grown from C$0.40 annually in FY17 to C$0.80 today.

Dustin has been central to TerraVest's capital allocation decisions throughout the period captured in the table above, and his incentives through equity remain fully intact. He is still in his early forties with what should be a long runway ahead as CEO at TerraVest.

So what are we paying today for TVK in the wake of the recent fall?

I value TerraVest on run-rate free cash flow rather than LTM figures, because the company completes so many acquisitions that trailing numbers consistently understate true earnings power. EnTrans, which is now a very significant part of the group, had a difficult year in 2025 due to softness in the tank trailer market, and the current numbers do not reflect its normalised earnings potential. Early data points for 2026 suggest the trailer market is beginning to recover, which should provide a meaningful tailwind to group earnings as the year progresses.

On a pro-forma revenue base of approximately C$1.85bn, accounting for full year contributions from all recent acquisitions, and applying TerraVest’s historical through-cycle free cash flow conversion of 10-11%, the business should generate approximately C$8 of free cash-flow per share.

At C$108 that is roughly 13.5x, against a peak of over 20x when sentiment was at its highest. Some compression is warranted given the governance overhang, but 13.5x for a business that has compounded EBITDA per share at c.35% annually over eight years feels like an overcorrection.

On the balance sheet, pro-forma net debt to run-rate EBITDA sits at roughly 2.6x. TerraVest has used a significant portion of its debt capacity over the past eighteen months, and with the equity issuance lever also impaired in the near term, another EnTrans-scale acquisition is unlikely in the short term. The more probable path is steady bolt-on compounding funded through operating cash flow, with more firepower rebuilding as earnings grow into the balance sheet.

In early May, TerraVest bought shares under its normal course issuer bid at C$117.50, a useful indication of where management saw value before last week’s events, with the stock now sitting below that level. My general rule of thumb with TerraVest to date has been to consider adding at or below 15x FCF and trim between 20x and 25x.

At C$80, or around 10x through-cycle free cash flow, I would be backing up the truck. At C$108 the stock looks attractively priced for a long-term investor and I added to my position at around that level. For someone not already in the stock this could be a reasonable entry point, though near-term volatility cannot be ruled out and my conviction is firmly in the medium to long-term picture rather than the next few weeks.

This is not a short-term trading call. It may take time for TerraVest to earn back the premium multiple it had been trading at, since that premium reflected confidence in the acquisition runway and the team’s ability to continue allocating capital at high rates of return. That confidence has been shaken and will need to be rebuilt through consistent execution and clarity on the Pellerin situation. Losing Charles is a genuine blow, and I do not want to minimise that. But with Dustin, Mitch and the broader team still in place, incentivised and with long runways ahead of them, I believe TerraVest has what it needs to continue compounding capital. The time to buy long-term compounders is when they are out of favour, and these developments have produced exactly that kind of opportunity.

Disclaimer: This is not financial advice and only for informational purposes. I hold a position in TerraVest Industries. Do your own research.

Market Cap: ~3.8bn SEK/ ~€350mn | ADV: 2,350 shares/ ~€72k

Summary:

Idun Industrier is a Swedish serial acquirer with a simple model: buy niche, market-leading industrial businesses at 5-8x EBITA, keep them operationally independent, and redeploy the cash they generate into further acquisitions. Do that consistently, add 5% organic growth on top, and you compound at 15% annually. Idun has done exactly that since inception, growing attributable EBITA per share at 16.6% per year from 2016 to 2025.

The reason the stock is interesting right now is that Idun is under-earning on two fronts. Sweden’s manufacturing cycle has been in a trough since 2023, dragging organic EBITA growth negative in both 2023 and 2025. Alongside that, management has deliberately run the acquisition engine below capacity while prioritising balance sheet discipline. Both are temporary. The question is not whether this is a good business, as the track record shows that clearly. The question is whether the recovery plays out as the data suggests it should, and whether the current valuation adequately compensates for the uncertainty in the meantime.

I believe the growth slowdown is cyclical rather than structural, with gross margins having held stable at c.60% throughout the downturn, competitive positions intact, and the businesses most affected, those serving pulp and paper, heavy process industry and industrial maintenance, operate in markets where deferred work cannot be deferred indefinitely. The PMI data is turning, Q1 was strong, and management guided Q2 stronger still. When revenue starts returning, the operating leverage is material, as the 2020-22 expansion demonstrated.

At SEK 330 the business trades at c.16x run-rate EV/attributable EBITA, broadly in line with Indutrade and at a meaningful discount to the proven serial acquirers. The management alignment is among the best I have encountered in a listed company of this size. At the current multiple, if Idun delivers something close to its historical compounding rate, the stock should return c.15% per year from here. The upside case is more interesting: operating leverage as the cycle recovers, a couple of years of above-target organic growth, and a gradual re-rating as the track record lengthens and the stock gets discovered beyond its almost entirely Nordic shareholder base is a combination that could produce meaningfully better returns over a three to five year horizon. I am happy to hold at current price, and would look to add on any meaningful weakness towards SEK 300.

Subscribe now

Background

Idun Industrier has been on my radar for some time. I first came across the name when I travelled to Stockholm in 2025 as part of ongoing research into serial acquirers, which are acquisition-driven compounders targeting at least 15% annual EBITA growth. I had more than ten meetings, back to back over two days, meeting large serial acquirers, emerging compounders and investors and brokers in the space. All shared a core, common focus on profitability, efficiency and growth, with varying approaches to get there. Success in this field requires the right mix of good people capable of making both operational and capital allocation decisions, wrapped in a high-performance culture and owner mindset. When I asked local experts which company they would put their own capital into, Idun was a name that kept surfacing as being of interest.

I have held a position ever since. With little written for public consumption on Idun, I finally sat down and did the work, and I thought I would add my thoughts to the public discourse for good measure. Here is what I found, and why I am happy to keep holding at the current price of SEK 330.

Sweden: The Spiritual Home of Serial Acquirers

For those unfamiliar with the asset class: Sweden has produced a remarkable concentration of acquisition-driven compounders, Lifco, Indutrade, Lagercrantz, Addtech, and a newer generation of challengers including Röko and Idun. This is not coincidence. Due to a confluence of factors, Sweden became the spiritual home of this movement: a rich industrial heritage dating back to the 19th century; a small and geographically isolated nation which was forced to embrace innovation and globalisation; a cohort of extremely wealthy families with a long-term ownership culture; a high-trust, high-transparency culture that makes acquisition transactions cheaper and less onerous than in most markets; and a culture of decentralisation that allows constant, stable development of acquired businesses. The result is giants like Lifco, Indutrade, Lagercrantz and Addtech that have compounded at high rates (often >20% CAGRs) for many years, large challengers like Röko, and now emerging compounders like Idun.

Note: REQ Capital are a leading voice in this space and have written well on this topic both in their book ‘The Compounders’ and in their other detailed writings on the space.

History, Founders & The Origin Story

Idun Industrier was founded by Adam Samuelsson in 2013. Adam had worked at Nordic Capital, one of Scandinavia’s most prominent private equity firms, buying and restructuring industrial companies before founding Idun. He has 20 years of experience investing in family-owned businesses and has been a board member at various companies including the Swedish compounder Bufab. The genesis for Idun came from Adam’s realisation while at Nordic Capital that instead of being forced to sell high-quality businesses every five to seven years in sync with the typical private equity cycle, just as they were really understanding the business’s key drivers and its potential, wouldn’t it be better to retain ownership and realise the potential of these businesses over the long term? In his own words, the idea was to keep and develop the fantastic businesses, rather than throwing the chips back on the roulette table.

Idun was seeded with Adam’s own capital and that of several wealthy families from his Nordic Capital network, including Robert Andreen, one of Nordic Capital’s co-founders. The Andreen family are the second largest shareholder with 10.5% of share capital, with Robert’s son Ludwig sitting on the board. It is noteworthy that c.44% of the share of capital is owned by the group management and board.

Included in that cohort is Gunnar Tindberg, the legendary Indutrade CEO from 1978 to 2004, who owns 0.6% and also contributes his skills in dealmaking, developing people and experience to Idun as a long-term member of the board. Mr. Tindberg built Indutrade into one of Sweden’s outstanding serial acquirers completing c.50 acquisitions with an exceptional 95% success rate, driving a c.20% CAGR during his 26 years at the helm.

“During its first decade, cost consciousness was so strong that the (Indutrade) head office was based out of a basement in a residential building in the mid-sized town of Malmö in southern Sweden. The office didn’t even have a sign on the door.” -- Indutrade Chapter, The Compounders Book, REQ Capital

Henrik Mella serves as CEO, having taken over in 2024 from Karl-Emil Engström, who moved to Deputy CEO and Chief Business Development Officer. Henrik’s background spans McKinsey, Assa Abloy, CEO of Cale Group and Group Pricing Director at Husqvarna, and pricing expertise is a recurring theme among the best serial acquirers: small family businesses often have never thought systematically about pricing, and the gains can be material. As these operators might say, if you haven’t lost a customer, you haven’t raised prices enough.

The whole parent company team comprises eight people in two rooms in a non-descript building in Stockholm, who conduct all investment work themselves, from target identification all the way to negotiation and closing. Idun avoids external advisers unless absolutely necessary, ensuring the team knows the companies inside out while saving costs, with a head office cost of SEK 25mn, overseeing SEK 2.4bn of revenue across 20 businesses.

Business Model & Acquisition Strategy

Idun is a decentralised acquisition-driven compounder. The model is straightforward in principle: acquire the majority stake of a target business, typically 70-90%, keep it operationally independent, extract the cash it generates, and redeploy that cash into further acquisitions. The difficulty is in the execution, which is why most attempts at this model fail and a few become compounding machines. Since inception Idun has acquired more than 35 companies across 20 group companies today.

The target company profile is specific. B2B industrial businesses in manufacturing, industrial trading or industrial services, with gross margins of c.60%, EBITA margins of c.14%, high market share often above 50% in their specific niche, and a track record of stability of profitability through multiple recessions. Many of Idun’s portfolio companies have been in business for over 100 years. Henrik has personally attended the centenary celebrations of two of them. Idun explicitly avoids consumer-facing businesses, turnaround situations and anything the team cannot understand thoroughly, preferring to tinker rather than make drastic changes and impose a new blueprint at companies they acquire.

Cultural fit matters as much as financial metrics. Idun looks for honest, reliable sellers who care about what happens to their business after the transaction, and has walked away from potential deals in the past because the fit was not right. Over 80% of deals are self-sourced, with the CEO and CFO regularly making cold calls to targets and building relationships over years rather than months. When the moment comes, those owners often choose Idun over a higher-bidding PE buyer because they know their business will not be flipped or reorganised. At a pace of only two to four deals per year on average, the team can afford to be patient and selective in a way that volume-driven acquirers cannot. They see themselves as value investors and typically pay 5-8x EBITA multiples, often including property. They have only ever sold one business, an aircraft maintenance company called TH Air, because a buyer emerged who was clearly a far better long-term home for it.

Idun compounds through three tools. New platform acquisitions at 5-8x EBITA are the primary engine, implying a day-one pre-tax return on invested capital of 12-20% before any organic growth. Bolt-on add-ons, smaller businesses absorbed into existing platforms, are a second tool. The third is ownership top-ups: buying out minority shareholders at pre-agreed valuation formulas embedded in the original shareholders’ agreement. In 2025 Idun increased its stake in Eugen Wiberger from 71% to 86% and in 2B Best Business from 70% to 98% through exactly this mechanism, essentially pre-purchasing future earnings at a known multiple in businesses they already know well.

Idun also owns SEK 264mn of property at book value across 28 properties and 98,000sqm, acquired alongside the businesses and held for the long term. Some carry environmental permits from the 1970s that create genuine barriers to entry, the market value is likely materially above book, and the portfolio provides a source of secured financing when needed.

The Businesses

Deep in the Swedish countryside, in the small town of Asarp, sits the Fredahl Rydéns factory. They make coffins and urns. If you die in Sweden there is a 65% chance you will be buried in one of theirs. In Norway the figure is 84%. Demand is directly tied to deaths, roughly 91,000 per year in Sweden alone, which should only increase as the population ages. This is the kind of business Idun owns, a dominant business in a specific, overlooked niche, with a dominant competitive position.

Idun currently operates 20 group companies across two segments, c.60% manufacturing and 40% service and maintenance, with more than 90% of revenue from the Nordics. The portfolio is eclectic: a precision engineering manufacturer making high-specification components for medical devices and vacuum technology, an industrial fastener distributor making 60,000 deliveries a year to Swedish factories, a provider of high-voltage maintenance for critical Stockholm buildings, a Nordic market leader in coffins. What they share is high market share in their respective niches, strong margins and long track records of profitability.

An example of a higher quality business is EKAB, employing c.20 certified electricians maintaining high-voltage infrastructure for hospitals, data centres and buildings in Stockholm that legally cannot lose power. The service is mandated by regulation with a 24/7 response requirement, and once you have route density across Stockholm it becomes effectively uneconomic for a competitor to replicate. With growing revenue and approaching a 30% EBITDA margin, EKAB is essentially unaffected by fluctuations in the business cycle, and represents the prototypical type of business that Idun would like to own.

At the other end of the quality spectrum sits Better Business, a mystery shopping and compliance monitoring service. Idun has acknowledged that this business proved vulnerable when customers cut discretionary spend during the downturn, the service not being non-negotiable in the way that regulated maintenance or funeral products are. It has been an underperformer, and is not the type of acquisition Idun will seek to replicate.

The portfolio spans that full quality spectrum, but is on balance considerably better than that contrast might suggest. At the top sit businesses with regulatory, demographic or contractual demand that is either non-deferrable or genuinely acyclical: EKAB, Fredahl Rydéns, Stegaföretagen’s car wash operations and the LMI group’s agricultural micronutrients and forest pest management products. Below that sits the majority of the portfolio, solid niche industrial businesses with defensible positions and often some cyclical exposure.

Recent acquisitions signal where the portfolio is heading. Trikåby, acquired in December 2025, runs at a 23% EBITA margin, nine percentage points above the group average. AGB, the most recent deal, runs at a c.22% EBITDA margin, servicing and calibrating pipe-pressing tools for plumbers who are required by insurance companies to have them regularly checked, which is as close to a captive recurring revenue stream as you find in a small industrial business. The table below gives the full picture for the group’s companies.

Subscribe now

Incentives & The “Pilot School”

Idun is among the most comprehensively aligned public companies I have encountered. Mella’s total compensation in 2025 was SEK 2.28mn, c.€210k including pension, a figure that speaks for itself for a CEO, when set against the peer comparison below. There is no variable remuneration for anyone at the parent company level beyond a modest warrant programme, and their wealth, like that of any outside shareholder, accrues through the share price over time. I think of Idun less as a conventional listed company and more as a family office executing an acquisition-driven strategy.

The management team all hold shares: Mella 1.2%, Jonas Sandström (first employee) 1.5%, Karl-Emil Engström 0.9%, CFO Oskar Samuelsson 0.7%. There has been some insider selling from Mella, Engström and Adam Samuelsson over the past year, each small relative to their total stakes. Warrant programmes are modest and market-priced, with maximum dilution across all outstanding series of less than 0.8% of shares.

The board reinforces the same ethos, with every board member a shareholder. The anchor investors from the 2021 IPO prospectus, the Andreen family (10.5%), David Mindus of Sagax (6.2%), Omar Alghanim, a Kuwaiti businessman (5.5%), and former Nordic Capital partner Ulf Rosberg (3.5%), are all still there which signals their conviction. The investor base is almost entirely Nordic, with Hanover Investors at 2.4% the only notable non-Nordic institutional name.

The alignment extends into all twenty group companies through what Idun calls the Pilot School. In every group company without exception, local management has personal ownership, ranging from production managers to MDs, with over 100 co-owners having taken stakes of typically 1-3%, often funded through personal loans.

When Idun acquires a business, the founder typically retains a minority stake under put/call arrangements that activate after three to five years. In practice they tend to stay far longer: the original owner of Intermercato was approaching retirement when Idun bought 70% of the business and is still there over a decade later. As Idun gradually buys out minorities, the share of group EBITA attributable to ordinary shareholders drifts upward, and currently stands at c.83%.

Overall, the alignment of interests between external shareholders and the people running this business is as tight as I have encountered in any listed company of this size.

Financials: Performance & Capital Structure

As of Q1 2026, Idun has LTM revenue of SEK 2,387mn and LTM EBITA of SEK 329mn, implying a 14% EBITA margin. Gross margins have been remarkably stable at c.60% across the full history, and EBITA margins have expanded from 10.7% at inception in 2015 to c.14% today, through a COVID year, a post-pandemic boom and a Nordic industrial downturn. That stability through the cycle is the clearest available signal that the portfolio quality is genuine. It should also be noted that Idun likely benefits somewhat from owning the property at many of its companies, which suppresses the rental cost line.

Q1 2026 net sales grew 15.7% to SEK 659mn with EBITA of SEK 91mn, up 16.8% year on year, the strongest Q1 on record. Organic sales growth was 5%, and management guided Q2 to be stronger than Q1.

Idun reports under K3 accounting rather than IFRS, which means goodwill is amortised rather than impairment-tested, suppressing reported EBIT and net income; EBITA is therefore the more useful metric, and the effective tax rate appears higher than Sweden’s 21% corporate rate because of the non-deductible goodwill charge. The business is relatively capital-light by industrial standards, with net capex of c.2.7% of sales and net operating working capital of c.18% of revenue, both broadly stable through the cycle, with much of the capex sitting in a grey area between maintenance and growth.

Idun’s net debt target is <3.5x, with net debt at Q1 2026 of SEK 939mn, equivalent to c.2.6x run-rate attributable EBITDA once Idun’s c.83% ownership share is applied, since virtually all group net debt sits at parent level and is fully borne by ordinary shareholders.

A March 2025 refinancing replaced expensive bond financing with cheaper bank debt saving SEK 20mn per year, and the June 2026 bond redemption saves a further SEK 8mn, adding c.4% to EPS per Carnegie estimates. A further SEK 40mn of annualised EBITA from recent deals not yet fully in the LTM brings run-rate group EBITA to c.SEK 370mn. After applying the attributable ownership share and the bond redemption saving, run-rate attributable FCF is c.SEK 200mn, equivalent to a c.5.3% FCF yield at SEK 330. Idun retains the great majority of this for reinvestment, paying a dividend of a maximum 10% of adjusted profit, currently SEK 1.15 per share.

How Idun Gets to 15% Growth

Idun's target is 15% annual EBITA growth, split 5% organic and 10% from acquisitions. Over nine years they have compounded attributable EBITA per share at 16.6%. Both engines have worked through the cycle, although not uniformly in every year, as the charts below show.

The math should work like this, in theory: On a run-rate basis the group generates c.SEK 200mn of equity free cash flow after interest and minorities, of which c.93% is reinvested after the dividend. Deployed at 5-8x EBITA, that implies pre-tax returns of 12-20% on incremental capital, and with 5% organic growth on top the combined engine should deliver the 15% EBITA growth target over the cycle.

The Organic Story

The total EBITA number at Idun has held up in recent years because acquisitions have more than offset the organic weakness, which is how the model is designed to work, but the organic line matters because it tells you whether the underlying businesses are healthy

The organic chart above tells the story clearly. Through 2020-22, the engine ran well above target, averaging c.19% across the three years as operating leverage kicked in on a fixed overhead base during a strong industrial cycle. Organic EBITA growth turned negative in 2023 at -7.9% and again in 2025 at -2.6%, dragged down by customers in pulp and paper, heavy industry and process maintenance deferring spend.

The central question for investors is whether this is cyclical or structural. Gross margins held stable at c.60% throughout the downturn, which is the clearest signal available that competitive position has not deteriorated, as structural deterioration would show up in gross margin compression before it reaches EBITA. The demand deferral argument is equally credible: machinery wears out and deferred work cannot be ignored indefinitely, least of all in Ståthöga, Triton and P&L Nordic where scheduled maintenance eventually has to happen. The average organic EBITA growth over the full history since inception is c.8%, comfortably above the 5% target.

It is worth being precise about the portfolio’s cyclical exposure, since not all of Idun’s businesses were affected equally. The manufacturing segment, which accounts for c.60% of revenue, carries more cyclical exposure through Intermercato’s machine attachments and Culina’s commercial kitchen equipment. The service and maintenance segment at 40% of revenue also contains significant cyclical exposure, most notably through Ståthöga MA Teknik, the group’s largest single cyclical business at c.9% of group revenue, which provides heavy industrial maintenance and fabrication services to paper mills, steel mills and process industry customers. When those customers deferred maintenance through 2023-25, Ståthöga’s EBITA margin compressed from c.17% in 2024 to c.10% in 2025 on lower revenue, and that single business was a substantial contributor to the group’s organic earnings decline, with correspondingly significant recovery upside. Both segments also contain genuinely defensive businesses: EKAB and Prowash’s car wash operations in service and maintenance, and Fredahl Rydéns’ funeral products in manufacturing.

The macro data is now supportive: Sweden’s Swedbank Manufacturing PMI rose to 57.2 in April 2026 from 56.2 in March, extending its run above the long-term average for a tenth straight month and reaching its highest reading since February 2022.

Q1 2026 provided the first hard evidence of recovery in the portfolio itself, with organic revenue growth of 5% and organic EBITA growth of 1%, modest but in the right direction, and management guided that Q2 should be stronger. When the cycle turns, incremental margins should be high as the overhead base is relatively fixed.

The Acquisition Story

The acquisition contribution has been more volatile, as the chart shows. The 2021 spike to 83% reflects five platform acquisitions in a single year funded by the IPO raise and two bond issuances, an exceptional deployment year that should be read as an outlier rather than a benchmark. The five-year rolling ROIIC of 16.1% confirms that capital deployed at 5-8x EBITA has generated returns comfortably above the cost of capital.

Acquired EBITA contribution was only 2.8% in 2024 and 5.2% in 2025, well below the 10% target, reflecting a deliberate decision to moderate the deployment pace as the industrial cycle weakened and balance sheet discipline took priority. With the March 2025 refinancing complete, headline leverage at c.2.4x EBITDA, and the pipeline active including the AGB deal announced in May 2026, the deployment rate should normalise through the year. Stegaföretagen’s own acquisition pipeline provides a further source of compounding that does not require Idun to deploy capital directly.

The attributable EBITA per share chart captures the combined effect of organic growth, acquisition deployment, ownership changes and share issuances in a single line. From SEK 5.73 in 2016 to SEK 22.76 in 2025, the CAGR is 16.6%, marginally above the 15% target on a per share basis over the full nine-year period.

Can Idun Hit 15% Growth Going Forward?

Q1 2026 came in at +16.8% total EBITA growth, with acquisitions doing most of the heavy lifting and organic beginning to contribute. The late 2025 and early 2026 acquisitions together added c.SEK 40mn of run-rate EBITA not yet fully reflected in reported numbers, and management guided Q2 stronger than Q1. Full year 2026 at or above 15% looks achievable, which would be the first year at or above target since 2022.

The underlying math for the longer term is straightforward. Internal cash generation of c.SEK 185mn per year after minorities and the dividend, combined with the SEK 450mn RCF and growing debt capacity as the group compounds at current leverage targets, is sufficient to fund the c.SEK 160-250mn of annual acquisition spend implied by the 10% acquired EBITA target at 5-8x multiples.

The honest caveat is that 15% will not come every year, and the organic component will be above target in strong industrial years and below it in weak ones, as the data above shows clearly. The question is whether the through-cycle average of 8% organic and the acquisition deployment of recent years is a fair guide to the next decade, or whether the early years of heavy IPO-funded acquisition spending flatters the historical number. On balance I think the model is intact, but investors should stress-test their own assumptions rather than take the historical CAGR at face value.

What the track record demonstrates is that the through-cycle average has met or exceeded the target: a business that compounds attributable EBITA per share at 16.6% over nine years through a pandemic, an industrial boom, a Nordic manufacturing recession and a rate cycle, while holding margins and balance sheet discipline throughout, has earned the right to be taken seriously on the 15% question but it is no guarantee they will necessarily meet it in the future. Over the medium-term, the upswing from here could be quite significant, as deferred organic growth returns and acquisitions resume at a normalised pace.

Capital Allocation

Serial acquirers live and die by the quality of their capital allocation. Storskogen, the other serial acquirer that listed in Sweden in 2021, which deployed capital at an unsustainable pace in 2021-22, acquiring poor quality companies and ultimately destroying shareholder value, is the cautionary tale. The best operators share a clear acquisition criteria they rarely deviate from, an aversion to overpaying, and an ability to maintain and grow businesses organically after acquisition.

Carnegie calculate that Idun has acquired companies at an average EV/EBITA multiple of 7.5x since the IPO, in line with the stated 5-8x range. In roughly half of those deals the transaction included the real estate used in operations, which typically attracts a higher multiple, meaning the implied multiple on the operating business alone is lower and day-one returns are therefore higher than they appear. The ROIIC calculation also requires adjustment for the unconditional shareholder contributions that Idun uses to inject equity capital into subsidiaries, SEK 130mn in 2025 and SEK 59mn in 2024, which represent real capital deployed but do not appear on the acquisitions line in the cash flow statement.

A few caveats before drawing conclusions from these numbers. The ROIIC includes organic EBITA growth in the numerator, which modestly overstates pure acquisition returns, though peers like Lifco and Lagercrantz are analysed on the same basis so comparisons hold. All figures are pre-tax, consistent with how serial acquirers are conventionally presented. Idun is also a younger group, meaning a larger share of the capital base reflects recent acquisitions that have not yet had time to compound. The five-year rolling ROIIC of 16.1% as of 2025 is the most meaningful single number, smoothing through the front-loaded 2021-22 deployment and the subsequent organic trough, and it has been remarkably stable.

One nuance worth flagging is the effect of minority buydowns. When Idun increases its stake in an existing subsidiary, the incremental EBITA flowing to shareholders goes up without any new operating capital being deployed into the business. It is arguably the highest-quality use of capital available to them: buying earnings they already know intimately, at a pre-agreed price, with no execution risk. The attributable EBITA share currently stands at c.83%, up from c.78% in 2020-23, and should drift higher as more minority buyouts are executed over time.

Idun is actively looking at acquisitions in other Nordic countries for the first time, and the team has appetite for geographic expansion beyond Sweden.

Idun’s capital allocation record to date is good. The path from good to great runs through continued discipline as the pipeline broadens geographically, the organic engine proves itself through a full recovery, and the returns on the existing capital base compound as the businesses acquired in recent years begin to mature.

Valuation

If the capital allocation record is a guide to what comes next, the valuation question becomes straightforward: is the entry price reasonable enough to generate an attractive return? At SEK 330 the entry is reasonable, although not overly cheap.

On an attributable basis, which is the right lens given the debt sits entirely at parent level and is fully borne by Idun shareholders, the business trades at c.16x run-rate EV/attributable EBITA and c.13x run-rate EV/attributable EBITDA as of Q1 2026. On a last twelve month basis those multiples are c.17x and c.15x respectively, reflecting the fact that several late 2025 acquisitions have their capital in the denominator but their full earnings not yet in the numerator. The adjusted P/E on Carnegie’s 2026 estimates, accounting for the interest cost saving from the bond redemption not yet in consensus, is c.18x, and the FCF yield on a run-rate attributable basis is 5.3%.

A note on reconciling these figures to the Carnegie peer valuation table published on 3 May 2026. Carnegie shows Idun at 12.8x 2026e EV/EBITA at their reference price of c.SEK 312 (implied from their market cap of SEK 3,592mn). At SEK 330, Carnegie’s 2026e EV/EBITA would be c.13.4x. The difference between this and the c.16x run-rate attributable figure above is explained by Carnegie using total group EBITA (100% of the group), while this piece uses attributable EBITA (c.83%), consistent with the fact that all of Idun’s net debt is borne by ordinary shareholders. Adjusting Carnegie’s 13.4x to an attributable basis gets to a c.16x multiple.

Against the peer group the discount is clear. Based on Carnegie’s numbers, the proven compounder average (Addtech, Indutrade, Lagercrantz, Lifco) trades at 21.3x 2026e EV/EBITA, and Röko at 18.7x. Idun at c.13-14x on the Carnegie total EBITA basis, or c.16x on an attributable run-rate basis, sits at the cheaper end of the peer group. Some discount is justified: Idun is younger, smaller and less liquid than Lifco or Lagercrantz, its organic growth has been more variable through the cycle, and its acquisition pace has been less metronomic, with deliberate slowdowns in 2023-25. None of these are structural criticisms but they are legitimate reasons for a valuation haircut relative to businesses with longer and more consistent track records.

The question is whether the current discount overcompensates for those differences. Over a full cycle the organic EBITA growth average has been c.8% and the five-year rolling ROIIC sits at 16.1%. Attributable EBITA per share has compounded at 16.6% since 2016, a strong track record achieved through a more challenging macro backdrop and with a younger, smaller portfolio than most peers. Lifco, for context, has a revenue base more than 10x the size of Idun's today. As that track record lengthens and the cycle turns, multiple expansion towards the 20-25x P/E range is the potential direction of travel.

A simple scenario analysis illustrates the return potential. If Idun continues compounding at its historical rate and the multiple stays flat at today’s c.18x forward P/E, the stock should compound at 15% p.a. The upside case is interesting with operating leverage as the cycle recovers, above-target organic growth as deferred demand comes through, and a gradual re-rating above 20x as the track record lengthens and the stock gets discovered. The bear case, multiple de-rating to 13x on disappointing organic delivery, implies a slightly negative return. That asymmetry, with the upside materially larger than the downside, is what makes the risk-reward interesting.

My own view is that SEK 330 is a fair entry into a well-constructed compounder at a point in the cycle where earnings are temporarily depressed, not a screaming buy but a reasonable initiation or add. I take a Turtle Creek-type approach: own it as a core long-term holding with the awareness that better entry and exit points will come along. I would be a more aggressive buyer below SEK 300 and would look to trim above SEK 420 as the multiple approaches the upper end of the peer range. At SEK 330 I am happy to hold, leaning towards adding on weakness.

Catalysts

(1) The Cycle Turns: Q1 2026 showed 5% organic sales growth, the strongest Q1 on record, but one quarter is not a trend. The H1 2026 results on 19 August are the test of whether that inflection is genuine, and two consecutive quarters of positive organic EBITA growth could change the narrative, proving that the trough of 2023-25 was cyclical rather than any structural deterioration in the businesses.

(2) Re-Rating as Track Record Grows: Idun trades at a discount to larger, proven compounders. This is partly justified by a shorter track record and lower liquidity. As the group compounds through a full economic cycle and demonstrates that capital allocation discipline holds up across different macro environments, that discount should narrow. The Swedish serial acquirer model commands premium multiples once trust is established, and Idun is still in the process of establishing it.

(3) Discovery and Uplisting: Idun began reporting earnings calls in English in Q3 2025, a signal that management wants to broaden the investor base beyond its almost entirely Nordic shareholder register. More international interest, paired with a move to the Nasdaq Stockholm Main Market, which management have indicated is possible over time, would broaden the eligible investor universe meaningfully.

Risks

(1) The Cycle Does Not Turn: If Sweden’s industrial recovery stalls in 2026, the organic recovery thesis could be delayed. The acquisition programme would continue regardless, but delayed organic recovery would slow progress towards the 15% EBITA growth target.

(2) Acquisition Quality and Supply: The long-term thesis rests on Idun continuing to source high-quality businesses at 5-8x EBITA. Overpaying, lower-quality deal flow, or increased competition from other serial acquirers would erode returns over time.

(3) Leverage: Group ND/EBITDA is c.2.2x run-rate, c.2.6x on an attributable basis. Comfortably below the 3.5x ceiling, but worth monitoring given the acquisition programme is funded partly through debt capacity. Excess leverage could constrain the acquisition programme and increases sensitivity to a higher rate environment.

(4) Key Person Risk: Eight people run the parent company. The loss of Adam Samuelsson or Henrik Mella, or other key personnel would be materially disruptive. The incentive structures that make departure unlikely are also the main mitigation.

(5) Controlling Shareholder: Adam Samuelsson controls 79% of the votes through Class A shares. Though the structure is in many ways more a feature than a bug, the dual class structure limits the prospect of a takeover bid and may preclude some institutional investors on governance grounds.

Conclusion

Having done the full work on Idun, the picture that emerges is of a business that is temporarily under-earning against a genuine long-term compounding track record. The portfolio quality is good rather than exceptional in aggregate. What is exceptional, and genuinely rare at this market cap, is the management alignment: a pedigreed team running a permanent capital vehicle where their wealth compounds through the share price alongside any outside shareholder, supported by 100 or so co-owners across the group companies, some of whom have taken personal loans to buy stakes in the businesses they run.

The thesis is straightforward enough. Idun is under-earning because Sweden’s industrial cycle is near a trough and the acquisition engine has been deliberately run below capacity while management prioritised the balance sheet. Both of those things are temporary. When the cycle turns, the combination of organic operating leverage, a normalising acquisition pace, and a track record that lengthens with each passing year should produce several years of above-target compounding. At SEK 330, with a 5.3% FCF yield, I am comfortable holding and would add meaningfully on any weakness below SEK 300. The businesses are good, the capital allocation has been good, and the alignment is exceptional. Whether Idun becomes the next great Swedish serial acquirer remains to be seen, but the foundations are as good as I have seen at this stage of the journey.

Disclaimer: This is not financial advice and only for informational purposes. I hold a position in Idun Industrier. Do your own research.

Sources: Idun Annual Reports 2018-2025; Q1 2026 Interim Report; Q1-Q4 2025 Earnings Calls; Redeye Serial Acquirers Conference 2026; DNB Carnegie commissioned research; Swedish company register (Bolagsverket) and Allabolag.se for subsidiary revenue and margin data. All figures SEK unless stated. Images copyright Idun Industrier AB.

For further reading: Paul Dutz wrote a good overview piece on Idun in 2024. Carnegie produce commissioned research on the company. REQ Capital, shareholders in Idun, have written extensively on Swedish serial acquirers and are worth reading for broader context on the asset class.

Market Cap: ~€9.2bn | ADV: 73,200 shares/ €13mn | 53.7mn shares outstanding

Pitch

D’Ieteren is a Belgian holding company trading at a c.50% discount to my estimate of NAV, where 80% of that NAV is concentrated in a world-class business, Belron, that should IPO in the coming year or so. The IPO will drive a re-rating of D’Ieteren’s NAV and, I expect, a meaningful compression of the holding company discount as their largest asset becomes publicly liquid and impossible to ignore. This double play makes D’Ieteren a core position for me with a two-year probability weighted IRR of 21%. A world-class asset base at half price, with a family-controlled shareholder that has a history of returning cash via special dividends. I like the asymmetric set-up here into the potential Belron IPO event, heads I win, tails I don’t lose much.

Subscribe now

History & Background

I have followed D’Ieteren for close to two years, having first done work on it around the time of the shareholder reorganisation and special dividend in late 2024. I thought it worth sharing now given there’s a clear catalyst on the horizon in the form of the mooted Belron IPO.

D’Ieteren is a seventh generation, family-controlled company that has been involved in the automotive industry and adjacent areas for over 220 years. As the Brussels Times highlighted: “Since 1805, the business has survived Napoleon’s march across Europe, Belgium’s independence revolution, two World Wars and, of course, the transformative arrival of the internal combustion engine.” The family business started when Jean-Joseph D’Ieteren began working as a coach-builder on the Rue du Marais in Brussels. The group entered what became its principal business, auto distribution, in 1931. Initially the group distributed US brands (none of which exist today) before getting its big break when it signed an agreement to import Volkswagen Group vehicles in 1948. In 1999, the group acquired what became by far its most impactful investment: Belron (50.3% ownership at present), the windscreen repair and replacement business. Since then, D’Ieteren has also added control or co-control stakes in TVH Parts (40%), an aftermarket parts distributor serving the material handling, construction, industrial and agricultural industries, PHE Europe (91%), a distributor of vehicle spare parts Western European countries, and in a departure from the group’s business services and light industrials focus, Moleskine (100%), the Italian lifestyle brand.

The business has been passed down the generations to its current owner Nicolas D’Ieteren, the second richest Belgian, whose net worth is substantially tied to his 50.1% stake in the group. Unlike many large family-controlled European companies, D’Ieteren has kept its shareholding consolidated along a single line rather than fragmenting across branches. This discipline was reinforced in 2024 when Nicolas bought out his cousin Olivier Périer, the former Deputy Chairman, in a transaction funded by a €4.3bn dividend recapitalisation at Belron. This helped fund a €4bn payout at the group level, including an exceptional dividend of €74 per share paid to all shareholders in December 2024. Nicolas’s family office Nayarit has increased its stake to 50.1%, while Olivier’s holding company SPDG Group has until 2029 to sell down its remaining 9.1% position.

Belron

Belron is the worldwide leader in Vehicle Glass Repair, Replacement and Recalibration (VGRRR) services. In 2024, Belron completed close to 17 million jobs across 40 countries, operating under more than ten major brands including Carglass, Safelite and Autoglass. It manages vehicle glass and other insurance claims on behalf of insurers, and operates through both a corporate business (North America, Western Europe and ANZ) and franchisees (typically in CEE, Africa and South America).

Belron was founded in New Zealand and has grown into the global leader in its category. Its US business, Safelite, accounts for approximately 55% of total group revenue and around 35% market share in North America, almost 10x the size of its nearest competitor. In some European markets, Belron accounts for close to two-thirds of the market. D’Ieteren first acquired a 68% stake in Belron in 1999 at an equity valuation of approximately €400mn. CD&R bought a 40% stake in 2018 at an enterprise value of €3bn, and sold roughly half of that to a consortium of Hellman & Friedman, GIC and BlackRock in 2021 at an EV of approximately €21bn (7x in four years). D’Ieteren currently own 50.3% of Belron.

Belron is led by CEO Carlos Brito, who took over in November 2022 having previously served as CEO of AB InBev from 2008 to 2021. He gave a good overview of the business at the 2025 Investor Day which is worth watching.

The Industry

Repairing, or increasingly, recalibrating a damaged windscreen is as close to a non-discretionary expense imaginable given its paramount importance for driver safety. The VGRRR market is expected to grow at a 7% CAGR from 2011 to 2031, driven by both volume and value growth.

Volume growth is stable and growing slowly, driven by the size of the car parc, miles driven, breakage rates and the propensity to repair. Value growth is more clearly positive: windscreens are becoming more complex, an ageing car parc in the US and Europe will need to be replaced leading to premiumisation, and inflation and price negotiations with insurers all push average revenue per job higher. Over the past five years, Belron’s volumes increased at an annual rate of just 1.1%, while organic growth averaged 7.9% per year mainly related to the most powerful tailwind of Advanced Driver Assistance Systems (ADAS).

ADAS involves cameras, sensors and radar arrays typically mounted in or behind the windscreen, which require full recalibration whenever a windscreen is replaced. Belron’s recalibration rate has grown from just 2% in 2017 to approximately 47% of the cars for which they repaired or replaced the windshield for in 2025 and has increased at c.5% a year for the last decade or so. Critically, almost 40% of those vehicles that now require recalibration essentially did not exist before 2017. New cars are legally required to carry ADAS technology in both the US and Europe, so this penetration rate will only rise as the fleet turns over and Belron will be well placed to capitalise on this trend.

The Moat

Belron benefits from numerous competitive advantages as the dominant operator in almost all of its markets, with leading technical and service capabilities, economies of scale and the ‘friendly middleman’ dynamic of its relationship with car insurers being among the most important.

Scale is the foundation, Belron replaced over 17 million windscreens in 2024, making it the world’s largest purchaser of windscreen glass. This procurement scale gives Belron a material cost advantage that compounds, and a wider range of SKUs available allowing Belron to stock the right glass for virtually any car model within reach of their technicians. Beyond procurement, Belron has leading technical expertise in ADAS recalibration and glass technology that smaller operators can’t match.

The insurance relationship is an important structural advantage and the hardest to replicate. Around 70% of Belron’s revenue is generated from insured jobs, with the remaining 30% from fleet and leasing companies and cash-paying customers. Car insurers typically operate nationally and they prefer to contract nationally with Belron than to manage hundreds of independent operators. For many drivers, a windscreen replacement is their only insurance claim in any given year or number of years, despite paying significant annual premiums. Replacing a car windscreen is one of the few moments an insurer gets to proactively impress a customer by delivering a high-quality, efficient service and so insurers prioritise service and technical expertise rather than just focusing on price. Belron understands this and has always focused on delivering a quality experience for the driver. Belron is also tightly integrated into insurers’ IT systems. All 25 of the top US insurers use Belron for claims processing through their third party administration business with State Farm, the last holdout, having just switched over in the last year.

Financial Track Record & Outlook

Belron has been a financial juggernaut for the last quarter of a century. Revenue has grown at a c.9% CAGR from 2000 to 2025, with adjusted EBIT margins expanding from 5.4% in 2017 to 23% today with trading cash flow conversion of c.80%. Since CD&R entered the cap table in 2018, growth has accelerated sharply, with EBIT compounding at 16% from 2021-2025.

In 2025, Belron delivered a record year on many metrics: 7.1% top-line growth at constant FX (18 bolt-on acquisitions contributed 1%) and an adjusted EBIT margin of 23%. Looking ahead, management guides to mid-to-high single-digit revenue growth in 2026, with continued margin improvement towards the 2028 target of >25%. The US market is normalising after a sharp period of insurance premium rises (US auto insurance prices rose approximately 40% from 2022 to Q3 2024) drove claims avoidance. Prices are settling (decreasing in places) which should result in more customers making claims through their insurance company again. CEO Francis Deprez mentioned at the FY25 results that the insurance companies are “doing their usual competitive behaviour” again which should be helpful for pricing into 2026 and beyond.

The business is capex-light, cash generative and deleveraging quickly. Net leverage at Belron fell from 5.5x at the peak of the 2024 recapitalisation to 4.5x (€8.4bn net debt) by year-end 2025 (despite paying a €307mn dividend in 2025), with successful loan repricings being achieved on both their dollar and euro tranches. Belron can deleverage at a rate of roughly 0.8x per year. The fact that Belron has operated at upwards of 5x leverage speaks to the stability of the underlying business. I would expect Belron to operate at closer to investment grade level and 3x leverage is probably where it trends to over time assuming Belron IPOs.

Ownership & The IPO

D'Ieteren Group holds 50.3% of Belron, CD&R 20.4%, Hellman & Friedman, GIC and BlackRock hold approximately 18% collectively, and management, employees and the Lubner family (via Atessa) hold the remaining 11%.

Given more than eight years have passed since CD&R first bought into Belron, the case for an exit is clear. The vehicle through which CD&R hold their remaining Belron stake is structured as a continuation fund, which will become five years old in the near term, adding further pressure to crystallise returns, given their lock-up on Belron expired in 2024. The full shareholding list of Belron is as follows:

In the last six months, the IPO chatter has moved from market gossip to credible public reporting. In January, the FT reported that Belron was in early talks for a €24bn IPO (equity value), implying an enterprise value of approximately €32bn, which could take place in New York or Amsterdam by end-2026. In early March, Bloomberg reported that Rothschild had been appointed by D’Ieteren to explore strategic options for its controlling stake, with the valuation range described as upwards of $30bn and close to $40bn. In April, the FT reported that Amsterdam had been chosen as the listing venue, though it noted that no final decision had been made and the deal could stretch into next year. CEO Francis Deprez was careful not to confirm anything, saying recently “we are very happy to be the majority shareholder of Belron. But other Belron investors may want to leave at some point. We will tackle that liquidity event if it happens.”

I think Belron would command an equity value of approximately €30bn in the public markets, consistent with what the financial press has reported. The transaction would likely be primarily secondary equity, though Belron may raise some primary capital to deleverage towards the 3x investment grade target (should be c3.8x by YE26). Amsterdam or New York are the realistic options as the listing venue, with Amsterdam the current favourite although I would have thought New York might make sense given over half the revenue is derived from the US and it might make more sense to report in USD. (Weakening USD was a headwind to Belron reported EUR results in 2025)

Should the IPO proceed, I do not expect D’Ieteren to be a significant seller. Based on management tone, I expect them to retain the vast majority of their stake, potentially taking a modest slug off the table to demonstrate the equity value is real and then most likely return it to shareholders or potentially redeploy while preserving optionality on the rest of the stake.

Other Segments

The remaining businesses are mixed performers. With the exception of Moleskine, all are involved in automotive or industrial parts distribution.

D’Ieteren Automotive: The group’s legacy business and the official distributor of Volkswagen Group brands in Belgium. The business holds approximately 23% market share in Belgian passenger cars. 2023 and 2024 were strong years as post-COVID supply chain disruptions resolved and inventory normalised. 2025 was tougher, with industry sales falling 7.5% and D’Ieteren’s own sales falling 9%. EBIT came in at €232mn, a 14% reduction on 2024 (4.7% margin). The business generated close to €150mn of free cash flow in 2025 and paid an exceptional dividend of €400mn to the parent, ending the year at below 1x net leverage. 2026 should see operating margin temporarily fall below the 4% mid-term target in a tougher market and with less support from VW Group. This is a cash cow at a tough part of the cycle.

PHE (Parts Holding Europe): 91% owned by D’Ieteren. PHE is a leading omni-channel distributor in the independent aftermarket for vehicle spare parts. D’Ieteren acquired PHE from Bain Capital in August 2022 at an EV of €1.7bn (c.7x EBITDA), with an effective equity cost of €571mn. PHE’s 2025 revenue grew 6% to approximately €2.9bn with adjusted EBIT of €267mn (9.1% margin). The business is performing well and consolidating a fragmented European market.

TVH: 40% owned by D’Ieteren (60% by the Thermote family). TVH is the world’s largest independent distributor of aftermarket parts for material handling, construction, agricultural and industrial equipment. D’Ieteren acquired its 40% stake in October 2021 for €1.17bn. Progress since has been disappointing. TVH proved more cyclical than anticipated, was hit by a cyber-attack in 2023, and is currently searching for a new CEO in a tough market for materials handling. 2025 revenue was approximately €1.7bn with adjusted EBIT down 15% to €223mn (13.4% margin). This acquisition has not worked out to date.

Moleskine: 100% owned. Moleskine is an Italian lifestyle brand best known for its notebooks. With 2025 revenue of €117mn, it is D’Ieteren’s smallest business. The acquisition of Moleskine has been a failure. D’Ieteren paid over €500mn for it and the business is currently loss-making, with a pre-tax loss of €8mn in 2025. Ennismore Fund Management, one of the more thoughtful long-term holders of D’Ieteren, characterised the acquisition as spending “over 20% of its market cap on an expensive acquisition of a subscale aspirational consumer brand with no connection to its core or its domain of expertise.“ It is a €600mn lesson the current management team better have learned from.

Central Costs & D’Ieteren Immo: D’Ieteren Immo manages the group’s Belgian real estate portfolio, most of which is occupied by D’Ieteren Automotive, and has a market value of c.€430mn and net rental income of close to €30mn. Group central costs of c.€30mn per annum cover HQ, salaries and reporting. D’Ieteren deserves criticism for poor transparency here by not splitting out their standalone central costs. Overall, these two more or less offset each other from a cash-flow perspective which is likely the reason management bundled them together.

Capital Allocation

D’Ieteren’s capital allocation track record outside of Belron has been underwhelming. Moleskine has been an absolute disaster and TVH has been disappointing. Only PHE, of the acquisitions made in the last decade comes out with any credit as it has executed well against its opportunity. Even Belron, which has worked out, only became an exceptional performer from 2017 which coincided with the ADAS tailwind and CD&R coming on board in 2018 (D’Ieteren sold 40% at an EV of only €3bn!) which leads me to question somewhat the quality of capital allocation at D’Ieteren, especially as they may soon have €15bn of liquid Belron stock to allocate.

D’Ieteren can write equity tickets for new platforms from €200mn to greater than €1bn, targeting business services or light industrials in Europe with scalable models, structural tailwinds and consolidation opportunities. The subsidiaries manage their own bolt-ons within their leverage constraints. My view is that at those cheque sizes, there are simply not enough high-quality opportunities to absorb anything close to the full value of a Belron monetisation. The math strongly suggests a sizeable portion of any Belron proceeds will need to come back to shareholders, including the controlling family, most likely via a special dividend. D’Ieteren has a history of this, paying an exceptional €74 per share dividend to all shareholders in December 2024.

Nicolas D’Ieteren holds 50.1% of the group through his family office Nayarit. His net worth is substantially tied to D’Ieteren’s share price, which is itself almost entirely driven by Belron’s value and he has every financial incentive to see Belron’s value realised fully and returned efficiently. The downsides of a family controlling a Holdco are usually around governance and self-dealing which I am not overly stressed about here. We are investing with Belgium’s second richest family who have demonstrated patient, long-term thinking as exemplified by their quarter century plus holding of Belron, which is to be admired given the many opportunities they likely had to take chips off the table along the way.

I am comfortable enough with likely capital allocation for now. Once Belron is public and D’Ieteren holds a large liquid position, the question of what happens with that capital becomes a key debate for the stock. My base case is that the math forces most of it back to shareholders, the cheque sizes simply do not support full reinvestment and Nicolas's incentives point in the same direction. I am not buying perfect capital allocation here, I am buying a world-class asset at a 50% discount, and the valuation below explains why.

Valuation

My approach is to value D'Ieteren on three components: The NAV of the underlying assets today (via a SOTP valuation with particular focus on Belron), the discount at which the market prices that NAV and how that may develop, which leads to a probability weighted scenario analysis of our likely total return including dividends.

The SOTP value is driven mainly by Belron as it accounts for c.80% of the group’s equity value. Belron doesn’t have any direct comps although there are press rumours that their Swedish competitor, Cary Group could be coming to market soon at a €3bn valuation, which previously transacted in ranges from 20x-25x EBITDA.

So what public comps should we use? D’Ieteren view Belron as a best in class, dominant business services company and would view some of the highest quality compounders in this space as their deserved peers. When looking at a comps sheet, Belron does share a lot of the traits of this grouping, with strong revenue growth (MSD to HSD), operating margins (>23%) and cash conversion which is encouraging. On the other hand, it is debatable whether Belron would garner similar valuations to these groupings from the get-go or whether the market would want to build trust in Belron as a public company first. If we look at high-quality Auto Aftermarket parts companies like AutoZone, O’ Reilly (high teens to low 20s EBITDA multiples) or even leading Business Services companies like Rollins or Cintas (mid to high 20s EBITDA multiples) it would suggest that a high-teens EBITDA multiple, which is what Belron has been transacting for in the private markets, is achievable for Belron in the public markets.

If we look at historical transactions, with credit to Andrew Brown of East72 Holdings for compiling the data, I note that the last two transactions, in 2021 and 2024, both transacted at just under 19x EBITDA.

At 19x 2026e EBITDA of €2,017mn I get to an EV of approximately €38bn for Belron and an equity value of approximately €30bn, consistent with the press-reported range, previous transaction multiples and potential comps.

The other assets have been marked at valuations either close to historical transactions, or at reasonable valuations based on the quality of business while taking into account peer valuations. Net debt is accounted for primarily at a subsidiary level with €287mn external net debt at group level as of the end of FY25.

The SOTP results in a NAV for D’Ieteren of just under €342 per share. This compares to a current share price of €172, meaning D’Ieteren trades at just under a 50% discount to my estimate of NAV.

Sum-of-the-Parts

At the current share price, taking everything else at NAV, we are buying Belron at only 10x EBITDA through D’Ieteren. At 19x, D’Ieteren’s 50.3% stake is worth approximately €15bn, or around €280 per D’Ieteren share before any group-level discount. Everything else, after debt, adds a further >€60 per share in net equity value.

Discount to a Discount

Despite a net asset value above €340 per share, most sell-side price targets cluster around the low-to-mid €200s and the stock trades at a discount to those targets again, in the low €170s. A buyer of D'Ieteren today is receiving two levels of discount simultaneously as analysts discount the NAV to get their price target, and the stock then trades at a further discount to that. Why?

The answer is the Holdco discount typically applied to family-controlled companies. A c.50% discount implies either that Belron is worth far less than the market reports suggest, that the cash will never come back to shareholders, or that D’Ieteren’s capital allocation will destroy the value it unlocks. I have addressed all three above. Part of the discount also reflects the fact that Belron is a private company. Investors cannot independently verify what it is worth and so discount the stated NAV accordingly to account for their uncertainty, an uncertainty that a listing would entirely remove. If the discount was partly pricing the opacity then an IPO removes that opacity.

From what I can see, sell-side analysts run a NAV exercise similar to mine, then apply what seems a relatively arbitrary discount that varies from analyst to analyst, resulting in a price target somewhere between the current stock price and their view of true NAV. In fairness, asserting where the discount should settle is a bit of a finger in the air exercise with relatively little proven methodology to guide us. Academic research on Belgian Holdcos specifically identifies four drivers of the discount: the Holdco structure destroys value through costs and poor capital allocation; the NAV is overstated; noise traders push the price below fair value; or the controlling shareholder extracts private benefits of control. I have addressed the first and fourth above. On the second, I do not think 19x for Belron is an overstatement given transaction history and public comps. On the third, noise traders and neglect are real, and a Belron listing would bring a wave of new analyst coverage and institutional attention that addresses exactly that. Forcing price discovery on a major asset is one of the most reliable mechanisms for compressing a Holdco discount.

So where could it settle? Comparable European Holdcos typically trade at discounts of 15% to 40%. The discount reflects real risks around capital allocation, governance, and the reinvestment risk of any proceeds, all of which I have addressed above. While I would not pay a premium to NAV, a discount in excess of 20% applied to a group where 80% of assets may soon be in a listed, liquid stock starts to be excessive. At just under 50%, where it trades today, it feels too wide and I would expect it to narrow over time.

Scenarios

The base case which assumes a Belron equity value of €30bn (19x EBITDA), that NAV compounds at 8% per annum, and that an IPO occurs with the discount narrowing to 40% over two years, generates a c.19% IRR. The bear case, where no IPO occurs and the discount stays at 50%, results in a -10% total return. The bull case, where Belron prices at the top of the range and the discount narrows to 25%, returns 132%. Probability-weighted, the expected IRR is approximately 21%. I like the asymmetry here given I am confident that the downside is relatively limited while the upside has a lot more room to run.

Risks

● No Belron IPO: Market conditions, macro volatility or a breakdown in shareholder alignment could delay or cancel the listing. The April FT report noted that no final decision had been made and that the deal could stretch into next year. If the IPO is delayed indefinitely, the discount is unlikely to compress and the investment case is significantly weakened, though not destroyed, as the underlying Belron value continues to compound.

● Capital allocation post-IPO: If D’Ieteren receives €15bn of liquid value and deploys it poorly, the discount is justified. Moleskine serves as a cautionary tale. The focus on deleveraging, structural constraints on cheque size, and the history of special dividends are defences against large scale capital destruction.

● Governance: Nicolas D’Ieteren controls the group. In 2024, he levered up both Belron and the group itself to buy out his cousin, funded by a special dividend that was taxed favourably for him in a way that was unavailable to most shareholders. While this was a one-time event, there is always potential risk that comes from a single controlling shareholder.

● Macro, trade, tariffs, FX and energy: Meaningful US revenue exposure at Belron and TVH creates vulnerability to adverse trade policy. Energy costs matter given gas is a key input in the glass Belron sources, and a stronger euro is a headwind to reported earnings.

● Cyclicality in the Other Businesses: Both D’Ieteren Auto and TVH are in a cyclical down-turn at the same time, which is putting downward pressure on group PBT.

● Long-term risk from Autonomous Vehicles and EV Risks: A successful roll-out of autonomous cars would reduce accidents and windscreen breaks which would be negative for Belron and more electric cars means less spare part demand for PHE. These are longer-term risks and I would expect the Belron IPO to happen before then!

Catalysts

● Belron IPO announcement: This is the primary catalyst and any formal appointment of underwriting banks or filing of a prospectus would increase focus on D’Ieteren and be a significant re-rating event.

● Capital Return: Even a modest return of capital post-IPO would signal that Belron proceeds will flow back to shareholders over time, likely compressing the discount materially and signalling the latent value at D’Ieteren. A more aggressive buyback or tender offer at current prices would be even more powerful for NAV accretion given the c.50% discount and its announcement would likely compress the discount itself.

● Trading Update and AGM on the 28^th May and first half results on the 9^th September.

Conclusion

D’Ieteren’s value stems from a world-class, growing asset that is likely to IPO and this value is hiding in plain sight. At a 50% discount to a NAV that will become increasingly liquid, this is just too cheap here. Downside is capped and the upside could be significant once Belron lists and gets properly priced in public markets. I have taken a core position in D’Ieteren and may size it up further into and around the potential Belron IPO.

The above is for informational purposes only and does not constitute investment advice. Always do your own research. If you found this useful, consider subscribing to ValueJunkie for more.

Subscribe now

Each issue I highlight a few pitches and ideas from fund letters, blog posts and presentations that caught my eye. I go through a lot of material and filter for what I think is worth paying attention to. I read thousands of investment idea pitches every year and thought I would share what I find interesting with a wider audience.

Alongside VJ Distilled, I will also be publishing my own investment ideas here. Subscribe to make sure you don’t miss them.

Full credit goes to the original authors. I’m just surfacing what I found interesting.

1. Marex Group | MRX US | $51.85 | $3.7bn Mkt Cap

Idea Source | @Kuppy | pracap.com

Note Q1 2026 results are due on Wednesday 6th of May.

The pitch (as of April 22nd, 2026):

Marex is a mid-market commodity broker providing clearing, execution and hedging to trading houses, producers and hedge funds across energy, agriculture and metals. Harris Kupperman (Kuppy) of Praetorian Capital dedicated a large portion of his Q1 2026 letter to the thesis. Kuppy believes commodity volatility is structural in a more fragmented world, and that mid-market commodity firms increasingly need to hedge risks they didn’t have to worry about before. He sees Marex taking share from bulge-bracket firms that are pulling back from the segment due to compliance costs and capital requirements. Revenue grew 27% in 2025, ROE was 27.6%. Looking towards 2027, Kuppy sets his fair value at $120 per share versus $52 today, at roughly 9x his 2027 earnings estimate.

Value Junkie View:

I have been a long-time reader of Kuppy, stretching back to the Adventures in Capitalism days to the present day through his quarterly letter. Kuppy is direct and open in his writing about his ideas. Praetorian focus mainly on themes related to inflation with holdings in land, energy, metals, refiners and select idiosyncratic opportunities like Marex. Q1 results for Marex are out on Wednesday morning, one to watch this week.

Marex appears to be set up well to continue taking share both organically and via M&A in a market that is growing due to increased external volatility. With clear incentives for executives to hedge out risks at the corporate level, Marex is positioned to continue benefitting from these trends. The stock has been on a good run YTD, up from $38 to $52 at the time of writing which would give me pause for thought not knowing a whole lot about the company. On the other hand, Kuppy points out that despite the appreciation, Marex trades at just high-single digit 2027e EPS with strong earnings growth and high returns on equity, while maintaining healthy levels of investment in their business. Sounds like there continues to be plenty of upside here, making MRX one to watch.

Subscribe now

2. Virtu Financial | VIRT US | $49.00 | $7.6bn Mkt Cap

Idea Source | east72.com.au | @East72Dynasty | Andrew Brown- X

The pitch (as of 31st March 2026):

Virtu is the only publicly listed pure-play liquidity provider in the US, a technology-driven market maker operating across equities, ETFs, fixed income and currencies. Andrew Brown of East 72 Dynasty Trust is a high-quality writer and drew on a presentation he gave at Value Spain in Madrid in March for this quarterly letter. Brown argues that US equity volumes have more than doubled from 7 billion shares a day in 2014 to over 20 billion today, driven by market democratisation via Robinhood and Interactive Brokers, the explosion of ETFs (now around 4,500 listed) and the shift to off-exchange trading which first crossed 50% of total US equity volume in November 2024. His more specific thesis is about a capital pivot. Brown points out that Virtu has paid away over $4 billion since 2017 in dividends and buybacks while competitors Citadel and Jane Street aggressively retained and deployed capital. From mid-2025, Brown believes Virtu changed course under new CEO Aaron Simons, with total deployed capital rising from around $3.8 billion to $5.1 billion by year end. Q1 2026 confirmed his view: adjusted EPS of $2.24 versus consensus of $1.25. Brown believes the stock at roughly 7x trailing earnings is pricing in a cyclical peak that he does not think is coming, and he puts his target at $6.75 EPS on a sustained basis once the capital deployment beds in.

Value Junkie View:

Andrew Brown is an investor whose letters I always pay attention to. He is a patient, concentrated investor who tends to own businesses where controlling shareholders are aligned with minority investors. He has written about Virtu across multiple quarterly letters, initially at $17 in September 2023.

I always pay attention to a change in capital allocation strategy, in Virtu’s case retaining more earnings which should enable management to grow Adjusted Net Trading Income (ANTI) while maintaining high returns on capital. The capital pivot story is the more interesting part of the thesis for me rather than the pure volatility trade. Q1 printed almost exactly as Brown predicted when consensus was sitting 78% lower, which gives the thesis credibility and also highlights how sell-side have been behind on Virtu. Given I am relatively new to the Virtu story, I would be interested to learn more about whether additional capital can actually recover market share that has drifted to Citadel and Jane Street, both of which are better capitalised private businesses with no pressure to ever return capital but Q1 earnings last week may be the first step towards Virtu proving that they can be more competitive. The stock is at $49, slightly below the level of $50.89 when the East 72 letter was published, which at least means it has not run away from readers since then.

3. IWG plc | IWG LN | 185p | £1.8bn Mkt Cap

Idea Source | @YaronNaymark | 1maincapital.com

The pitch (as of April 2026):

IWG is the world’s largest flexible workspace operator, running Regus, Spaces, HQ and other brands across 120 plus countries. In February 2026 the stock fell over 25% after Citrini Research published a viral Substack post imagining an AI-driven economic collapse scenario. Markets sold off white-collar adjacent businesses as if the scenario was a forecast rather than a hypothetical exercise. Yaron Naymark of 1 Main Capital believes the market read this completely backwards. He argues AI drives startup formation and makes enterprises reluctant to commit to long-term office leases, which increases demand for IWG’s flexible model. He also argues that AI-driven office vacancies create more building owners willing to partner with IWG under its managed partnership model, where IWG operates the space for roughly 15% of revenues and takes on zero capex. Naymark points to the full year 2025 results as evidence the business is not in distress: system-wide revenue of $4.5 billion, EBITDA of $531 million, free cash flow up 60% to $162 million, with net debt declining. He believes the stock trades at under 3x 2030 estimated free cash flow if management’s £1 billion EBITDA target is achieved.

Value Junkie View:

Yaron Naymark founded 1 Main Capital in 2018 and has compounded at 20.8% net annualised since inception. He runs a concentrated portfolio focused on high-quality businesses with long reinvestment runways. In terms of style and investment holdings, Yaron is an investor I have had a lot of overlap with over the years.

He is among a number of investors who have followed IWG for a number of years and are bullish. I have done a little bit of work on IWG in the past and was intrigued. I never got around to completing my work on it or getting to a place of conviction. It is definitely true that IWG is a very controversial stock with bulls and bears with strong opinions on both sides. I would want to do a lot more work on understanding the business model transition, assessing its quality, their leases and bridging actual results to IWG’s targets in more detail.

This is a business model transformation that is playing out over the coming years as they move towards this capital light strategy. If they deliver their plans, IWG is potentially a very cheap stock with huge potential upside. On the flip side, I have spoken with bears who question the credibility of management as well as the quality of the business model. A Substack post causing a 25% decline in a business reporting record free cash flow is a setup worth paying attention to, especially in a company that is buying back shares in the open market.

4. Raiffeisen Bank International | RBI AV | €45 | €14.8bn Mkt Cap

Idea Source | @UV_Shares | undervalued-shares.com

Note: Q1 2026 results are due on Tuesday 5th May.

Note: Source article is behind a paywall at Undervalued Shares.

The pitch (as of April 2026):

RBI is an Austrian bank operating across Central and Eastern Europe with 17.9 million customers across 11 markets. The Russian subsidiary has been the overhang keeping the stock cheap for years. Swen Lorenz of Undervalued Shares first wrote about RBI when the stock was €13 and has continued to follow it closely. He believes the Russia overhang is resolving and that the market is still not pricing the core CEE franchise correctly. Swen argues that stripped of Russia, the core business trades at roughly 5.5x 2027 estimated earnings and 0.6x book value, versus the average European bank at c.9x PE. He also points to active capital deployment as a sign of management confidence: a voluntary takeover bid for Addiko Bank and the acquisition of Garanti BBVA Romania both announced in recent months, positioning RBI as the consolidator of a fragmented banking landscape in CEE as Western European banks retreat. Swen sees Ukraine reconstruction as additional optionality on top of what he already considers a cheap core franchise. RBI has more than tripled since he first covered it and he still considers it one of the best proxies for investing in the CEE region.

Value Junkie View:

Swen Lorenz has over 30 years of investing experience and runs Undervalued Shares, a research service focused on finding opportunities that mainstream investors overlook. He has a strong track record of finding early-stage situations in less-followed markets. His original RBI call at €13 was specific and ran counter to consensus at the time.

I like that RBI is consolidating the market by making accretive acquisitions in CEE. Q1 results out tomorrow give an immediate read on the core business. What I would want to understand better is the governance questions, actual Russia exit timeline, what residual regulatory and legal exposure looks like post-exit, and whether the CEE re-rating happens on its own or needs a specific Ukraine catalyst to get there. Worth flagging that the Russia situation is genuinely complicated and this is not a clean story. Overall, one of the strongest banking franchises in an outperforming CEE banking market with M&A consolidation opportunities at 5.5x looks interesting especially with potential upside optionality from an exit of their Russian subsidiary.

Note: This post is for informational purposes only and does not constitute investment advice. I may hold positions in securities mentioned. Always do your own research before making any investment decision.

If you found this useful, please subscribe for more VJ Distilled editions, as well as to receive investment ideas and analysis from Value Junkie.

Better Plan, Now Down to Execution

Whitbread is not the type of business I would normally invest in but the activist involvement here caught my eye. Capital allocation has been poor, underlying earnings growth has been so-so, the UK hospitality environment is genuinely difficult, and management have just abandoned one five-year plan after 18 months. The stock is down 30% over the last five years, near-term earnings momentum is weak and sentiment is at a low ebb. That said, this week’s announcements are worth paying attention to. Pushed by an activist, management seem more open minded and have taken real and uncomfortable steps to reset the business to become a leaner, more pure-play hotel operator: exiting food and beverage, cutting gross CAPEX by £1bn, recycling £1.5bn of property, cutting 3,800 jobs, and shifting from growth-at-any-cost to a returns focus. This is a management team trying to regain credibility and they are under big pressure now to deliver this plan with the activist investor, Corvex, present on the register.

The stock is cheap on normalised cash flow, the property floor limits the downside, and the right tail is interesting. Feels like sentiment is close to a bottom after yesterday’s earnings downgrades. If the market still fails to rerate after delivery, Corvex has every incentive to push for something more radical. I think this is a reasonably cheap entry (£22 SP, <12x earnings), with bombed out sentiment, an activist backstop, and structural optionality. I’ve taken a small tracking position.

This ship will take a while to turn and I’m not in a rush to take a meaningful position here as this plan is a five-year story. I'd need to see early signs of delivery before pressing the position further. Execution was the problem with the last plan and it remains the key risk here.

Subscribe now

A Reluctant Reset: Better Tone, Abandoned Targets, Capital Allocation Finally Improving

The stock fell over 6% yesterday on the day of announcement. The sell-off was driven by the FY27 earnings downgrade that wasn’t fully baked in by sell-side consensus. Headwinds from business rates, the Accelerated Growth Plan extension, inflation at the top of the guided range, and a £5mn hit from the Middle Eastern JV hurt FY27 guidance. Buybacks have also been paused. Some brokers had flagged this but consensus had not come down enough and the market sold the stock on this. I thought that the market might look through this more, or have already incorporated it, but the stock sold off on the earnings downgrade with the strategic reset an afterthought. FY26 itself was decent: adjusted PBT flat at £483m despite real cost headwinds, Germany profitable for the first time at £2m, cost efficiencies beat at £83m, and UK RevPAR outperformed the market.

The management tone was noticeably candid. CEO Dominic Paul acknowledged on the call that Germany was run with a UK mindset from the start and that they overpaid for some sites that do not fit the model as it has evolved. That level of honesty is refreshing. The broader acknowledgement that capital allocation has not been returns-led and that the FY30 plan is being scrapped after 18 months was overdue. The new plan runs to FY31.

In fairness, management have been genuinely unlucky in places. The UK government reaching for business rates and national insurance to plug the fiscal hole was a material and largely unpredictable headwind that changed the economics of projects that were viable under the prior plan:

“It is fair to say that the last two UK budgets have not been kind to the hospitality sector... taken together, these factors have hit the whole hospitality industry hard. For us, before mitigation, they are expected to reduce future profits by around £160m.” — Dominic Paul, CEO

At the same time, Whitbread management have created enough of their own problems. They over-invested in expansion, chasing growth for the sake of it at the expense of returns. Germany was underperforming before business rates were an issue and the prior expansion programme was too aggressive regardless. Some of this reset is clearly Corvex-driven. The activist took a 6% stake in December 2025 pushing for exactly this, a reduction in the property discount and more disciplined capital allocation. Corvex have not made money here and will keep the pressure on. The question is whether management can execute a second plan having failed to deliver the first. If they cannot, board representation is the logical next step for Corvex.

The most significant shift is from growth and market share towards returns on capital. UK room growth targets are reduced, pipeline projects below hurdle rates have been exited, and the Germany room target has been cut from 20,000 to 18,000 rooms. Dorchester is the clearest example, planning consent had been secured but the site is now being sold because business rates pushed the return below internal hurdles. The CEO was explicit on the call that this is no longer about chasing a growth target for the sake of it.

The Plan: Exit Restaurants, Cut CAPEX, Recycle Property & German Improvement

So what does the updated plan actually look like? The headline numbers are: £1bn gross CAPEX reduction over five years, £1.5bn of freehold property recycled, net CAPEX at £200-250m per annum versus £500m previously, freehold ownership falling from 50% to 30-40%, £275m of incremental PBT targeted by FY31, and a 500bps ROCE improvement to around 16%.

The most operationally significant decision is extending the Accelerating Growth Plan to cover all remaining 197 branded restaurants. These currently generate £284m of food and beverage revenue but run at a site-level adjusted loss of £13m before tax, plus £10m of central overheads. Management are converting 87 into hotel extension rooms and selling or closing the remaining 110 over the next two years, involving around 3,800 job losses, a direct consequence of UK government policy making the operation uneconomic. The transition hits FY27 profits by a net £10m and the full £100m incremental PBT benefit is not seen until FY31. Simon Ewins put the economic logic plainly:

“The average margin across our 500 integrated sites is around 10 percentage points higher than it is for sites served with a branded restaurant.” — Simon Ewins, MD UK Operations

On property recycling, the net CAPEX reduction is the most important financial change in this plan. Gross CAPEX falls by £1bn over five years, but more importantly net CAPEX drops from around £500m per annum to £200-250m, funded by recycling £1.5bn of freehold property. That halving of net capital intensity is what drives the step-up in free cash flow and shareholder returns over the life of the plan. Management sell mature freeholds at 5-6% yields and redeploy into the AGP at guided 15-20% returns. The spread is attractive if it comes through. Most shareholders would probably prefer the proceeds back via buybacks rather than trust management to redeploy at those rates given the track record, but if the AGP delivers what management expect the redeployment is likely accretive. The capital return story is back-end loaded: no buybacks in FY27, Germany cash flow positive by FY29, and the full £2bn shareholder return target not reached until FY31.

Germany is the part of the plan that requires the most faith. The business turned profitable for the first time in FY26 at £2m of PBT, with Hamburg already delivering double-digit site-level returns, and management now have a clearer view of what works, larger city centre hotels in the right locations. The room target has been cut from 20,000 to 18,000 and all future growth will be funded via leaseholds or property recycling. Encouraging progress, but brand awareness sits at 19% in Germany versus over 90% in the UK and the journey to profitability took far longer than expected. There is a lot of execution risk and it remains to be seen what returns on capital the >£1bn German investment will ultimately deliver.

Low Expectations… Worth Tracking Execution

UK hospitality is not a sector you would generally seek out. Roughly six businesses are closing per day in 2026. But the activist involvement, the reset, and the valuation together create a situation worth paying attention to. There is genuine turnaround and re-rating potential here if management execute, with the property estate providing a floor on the downside.

On normalised cash flow, stripping out expansion CAPEX and assuming the plan broadly delivers, the stock looks cheap relative to the current market cap. That yield improves significantly, well into the teens, as the AGP completes, Germany matures, and the cost programmes work through. There are three things to watch closely for over the next 12 months: (i) the disposal yield holding near the FY26 level of 5.4% on £450-500m of guided FY27 proceeds, (ii) early AGP site performance as more completions come through, and (iii) any signal from Corvex on whether they are satisfied or pushing harder. If those are moving in the right direction by the interim results, the case for building gets considerably stronger.

The risk-reward looks more interesting than it has for some time. Earnings downgrades are out of the way, sentiment is at a low ebb, and the right tail is genuinely interesting. If management execute and the market still fails to rerate, Corvex has every incentive to push for something more radical. At this price relative to asset value and the stock’s own history, the case for a more fundamental review only grows stronger the longer the discount persists. The business is becoming simpler and easier to underwrite, a cleaner candidate for some form of transaction if the new strategy does not close the gap.

The key risk is the same as it was with the last plan, execution. That is why I have taken a small tracking position, watching closely.

Note: This post is for informational purposes only and does not constitute investment advice. I may hold positions in securities mentioned. Always do your own research before making any investment decision.

If you found this useful, consider subscribing to The Value Junkie for more ideas and analysis.

Charts and data

1. Group financial summary

2. Summary of New Five-Year Plan Guidance

3. External Challenges

4. Capital Allocation

5. Key Initiatives to FY31

The Setup

The market has punished Whitbread for a combination of poor capital allocation, a weak UK trading environment and rising costs. Business rates following the Autumn Budget added a £35m annual headwind from FY27. NIC increases and labour inflation compound the pressure. RevPAR was negative for six consecutive quarters before a partial recovery in Q3 FY26. The five-year FY30 plan set in 2024 is being reset after 18 months and Germany, the long-term growth story, is only turning profitable now. The stock currently trades at just over £24, close to its five-year low and the stock price has gone backwards over the last five years. (Image Source: Google Finance)

The result is a company trading at a c.£4.6bn EV against an independently verified property portfolio worth c.£6bn, meaning the market is ascribing zero to negative value to the operating business. That operating business is Premier Inn, the dominant UK budget hotel operator with 86,000 rooms and approximately 40% of the UK branded budget segment. This dislocation attracted Corvex Management, a proven activist, which took a 6% stake in December 2025 and has publicly forced management to reassess their Five-Year Plan, including the £3.5bn investment programme.

The downside is anchored by the property floor. The upside is a forced capital allocation reset, with a hard public deadline of April 30th.

Subscribe now

Background

Whitbread (WTB LN) is a FTSE 100 hospitality company and the owner and operator of Premier Inn, the UK’s largest budget hotel chain with over 86,000 rooms across more than 800 hotels. It also has a growing presence of over 11,000 rooms in Germany. Once a sprawling conglomerate with interests in Pizza Hut, Costa Coffee and Stella Artois, it has spent the last decade simplifying into a focused hotel business.

What makes Whitbread an anomaly in the global hotel industry is its ownership model. The modern hotel playbook, adopted by Marriott, Hilton, IHG and Accor, is asset light: these groups franchise or manage hotels owned by third parties, collecting fees without tying up capital in property.

Whitbread never made that journey. It owns 51% of the hotel rooms it operates, sitting on a property portfolio independently valued at up to £6.4bn. That asset has been hiding in plain sight for years, and the SOTP argument has long been discussed. The reason it has never fully re-rated on this basis is straightforward: structural value that cannot be unlocked is theoretical value. A company sitting on a property portfolio worth more than its market cap is interesting, but not necessarily actionable if management has no intention of doing anything about it. The SOTP has historically been a framework that showed the discount without providing a reason for it to close.

What has changed is Corvex. The presence of a credible, well-resourced activist with 6% of the company and a public position on the property discount transforms the previously theoretical into something that now has a realistic path to realisation. April 30th is the first hard test of whether that path is opening.

Who is Corvex?

Corvex Management is a New York-based activist hedge fund founded in 2010 by Keith Meister, who spent years as a key lieutenant to Carl Icahn before striking out on his own. The fund manages approximately $3bn and runs a concentrated, fundamentally-driven book with a longer-term investment horizon than most activists. Meister’s approach is less table-thumping than some of his peers: he prefers to engage constructively with boards and management teams, treating activism as a last resort rather than a first move.

His track record of forcing structural change and unlocking value at companies with complex capital structures is well established. He pushed for management changes at CenturyLink, partnered with Icahn to force the sale of Energen Corporation, and has repeatedly targeted situations where he believes the market is undervaluing assets trapped by poor structure or capital allocation. The fact that Corvex chose Whitbread, a UK-listed company outside its usual hunting ground, and took a 6% stake with a public letter calling out the property discount, signals serious conviction and intent to follow through.

Catalyst: April 30th, Three in One

FY26 results, an updated strategy, and rebased FY30 targets all land simultaneously on April 30th. This is a rare convergence of catalysts.

The base case is CAPEX rationalisation, reset targets, and accelerated sale and leaseback transactions beyond current guidance. The January 2026 LondonMetric transaction (£89m across 9 sites at a 5.3% NIY) confirmed the sale and leaseback programme works beyond prime London assets.

A full PropCo/OpCo split is operationally complex and unlikely on the day, but cannot be ruled out given Corvex’s public position on the property discount. The CEO committed on the January earnings call to reviewing “all options.”

Update, Sunday Times April 25th: Whitbread is expected to announce the sale and leaseback of one in five freehold properties it currently owns, releasing approximately £1.5bn for shareholders. This would reduce freehold ownership from roughly 50% to 40% of Premier Inn hotels, turning Whitbread into a majority leasehold business for the first time since Premier Inn was founded in 1987. Deutsche Numis described the April 30th announcement as “particularly important” while analysts at Morgan Stanley said the revised plan should “reassure investors.”

The stock reacted with a 3% gain on Monday morning following the article before retracing the move by the close. That is an interesting data point in itself. Either the market is treating it as just a rumour until confirmed on Thursday, or the scale of the strategic shift has not yet been fully absorbed. Either way, with the confirmed announcement two days away, the move has faded rather than been built upon.

Valuation: Two Frameworks, Same Conclusion (Roughly)

Sum-of-the-Parts (SOTP)

Separating Whitbread’s property and operating businesses:

The independently verified RICS portfolio is valued at £5.5bn to £6.4bn at yields of 5.5% to 6.5%. The OpCo, if it were to pay market rent on those properties, would earn approximately £400m of EBITDA (maybe more), which I value at 9x, reasonable for a dominant branded operator. Deducting net financial debt, SOTP fair value is c.£50 per share against a current price below £25.

As noted above, this SOTP has been visible to the market for some time without closing the gap. The difference now is that Corvex has latched onto the same framework and is actively pushing to make the theoretical real. That is what makes the timing of this interesting rather than just the valuation itself.

One genuine caveat worth flagging: the RICS valuation reflects Whitbread as a strong, creditworthy tenant on a relatively modest rent burden. As more properties are sold and leased back, the total rent obligation grows, fixed charge cover deteriorates and subsequent buyers of freeholds may demand higher yields to compensate for a weaker covenant. In practice this means the first tranches of the S&LB programme clear at tighter yields (the LondonMetric deal at 5.3% NIY supports this) while later transactions may be done at 6.5% to 7% or wider. The programme has diminishing returns at scale, and the aggregate proceeds are unlikely to reach the top of the RICS range. The base case is probably the right anchor rather than the bull.

Traditional Multiples

Even rejecting the SOTP framework, Whitbread trades at 8.5x EV/EBITDA and 12x P/E against five-year pre-pandemic averages of 10x and 16x respectively. Both frameworks point to the same conclusion: Whitbread is undervalued relative to the latent value trapped by its current structure, which is now being addressed.

As Corvex stated plainly in December 2025, the current share price appears to ascribe no value to Whitbread’s UK operated leasehold portfolio, its German hotel assets, or its development properties under construction.

The Short Position and Why It’s Interesting

WTB is the fifth most shorted stock in the UK, with 9.2% of the float disclosed short according to ShortTracker. Names include Marshall Wace, Millennium, Citadel, D.E. Shaw and Two Sigma. A who’s who of multi-strategy pods, not tourists.

The shorts are probably focused on near-term earnings risk into April 30th. Given these managers have the resources they do and focus on these events they may well be right that Whitbread is under near-term earnings pressure. The EPS headwinds are real and well documented: the £35m business rates hit in FY27 rising under transitional relief over three years, NIC and labour inflation, and the ongoing German drag. Sell-side numbers have been coming down, and it is likely consensus has not yet fully caught up with where updated buyside expectations have settled, which could pose guidance risk on the day. The shorts could be right on earnings, and I am not going to argue otherwise.

Where it gets interesting is whether April 30th reframes the conversation entirely, away from near-term EPS and toward structural value realisation. The thesis here is not that earnings are great. It is that there is significant value trapped in the structure of this business that Corvex is pushing hard to unlock. If management delivers something credible on April 30th, the question shifts from “when does EPS recover?” to “how much capital gets returned and when?” which could change the narrative.

Risks and Mitigants

(i) Management disappoints on April 30th Delivers only incremental changes with no structural commitment. Mitigant: the stock is already mispriced on a standalone property basis, and Corvex with 6% would be expected to escalate.

(ii) Near-term EPS pressure Business rates £35m FY27 headwind increasing under transitional relief over three years, plus NIC and labour inflation. Mitigant: Whitbread has a strong track record of cost delivery (c.£80m in FY26), though full offset over the three-year transition is not assumed.

(iii) Sale and leaseback at scale creates permanent rent costs and diminishing returns Later transactions in the programme may happen at materially wider yields as the covenant weakens, reducing aggregate proceeds below headline RICS-implied values. Mitigant: £1bn+ of Group EBITDAR with rent cover intact, and the value unlock remains significant even at wider yields on later tranches.

(iv) Weak UK economy and consumer RevPAR recovery depends on supply continuing to tighten. A weaker-than-expected UK economy could delay or reverse this. Mitigant: structural supply dynamics from independent hotel closures and below pre-COVID supply levels provide a tailwind independent of demand.

(v) Germany continues to drag The German business is only now profitable after years of capital consumption. A slower path to profitability would weigh on group earnings and capital allocation credibility. Mitigant: German RevPAR up 7% in Q3 FY26 and the business is on track to reach profitability this year.

(vi) Corvex has no confirmed board seat Mitigant: 6% stake, a public letter, a hard April 30th deadline, and Meister’s track record of escalation.

What to Watch

April 30th is the key date. A strategy reset, a move toward a more capital-light model, CAPEX rationalisation, meaningful capital returns and rebased targets would likely be taken well by the market. The interesting thing is that this combination does not yet appear to be catching the attention it probably deserves. April 30th may change that.

The question is whether management delivers something structural or merely incremental. A credible sale and leaseback programme and CAPEX rationalisation would likely reframe the investment case meaningfully. A same-as statement with no structural commitment would disappoint, though the property floor limits how far the stock can fall from here.

Corvex’s next move is the other thing worth watching. With 6% and a hard public deadline, the activist dynamic does not go away quietly regardless of what management delivers on the day.

This is not financial advice. Do your own due diligence.

Leave a comment

A running index of everything published on this Substack.

Deep Dives

D’Ieteren (DIE BB): The Belgian Holdco Hiding a World-Class Business at Half Price
80% of NAV sits in an exceptional business about to go public, yet the stock trades at a 50% discount to NAV. The Belron IPO looks increasingly likely and D’Ieteren is the only way to play it.

Idun Industrier: The Next Great Swedish Serial Acquirer That Nobody Talks About?
Sweden has produced the world’s greatest concentration of acquisition-driven compounders. Idun is the most aligned of the emerging generation, and right now it is under-earning.

TerraVest: Chairman Insider Trading Allegations, and Why I Added on the Drop
A significant governance blow, but a 32% drop feels like an overreaction for a business whose compounding engine remains intact.

Situation Updates

Whitbread (WTB LN): Checking Out of Restaurants, Checking Into Returns Focus
FY26 results and strategic reset: shedding restaurants, cutting capex, and management shifting to a returns focus. Right steps, execution risk remains, Corvex lurking.

Whitbread (WTB LN): An Interesting Activist Situation
Activist-driven strategic review highlights potential to unlock value, with a shift toward a capital-light model as a key lever.

VJ Distilled: Ideas to Watch

4th May 2026
Four ideas worth putting on your radar: a commodity volatility beneficiary, a capital pivot the market has not priced, an AI panic selloff, and a cheap CEE banking consolidator.

Updated as new pieces are published. If you want these in your inbox, subscribe below.

Subscribe now